Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Soon after her husband Uwe died in the summer of 2015, Unislim managing director Fiona Gratzer began experiencing intense and ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

If you’ve been holding off on joining a weight loss program because you’re apprehensive about the cost, you’ll be glad to ...

The nature of the weight loss drugs — large amounts of people ... themselves is to always get the brand-name product through a prescription from a doctor. He acknowledged that other people ...

CNW/ - A new Nanos Research survey commissioned by Felix Health reveals that 60% of Canadians struggled to meet their most ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

MBX Biosciences reports Phase 1 trial results for MBX 1416, a GLP-1 receptor antagonist for post-bariatric hypoglycemia. Phase 2 starts in 2025.

Discover how North Dakota is leading the way by covering Ozempic for weight loss under ACA plans, making it the first U.S.

Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...